Valeo Financial Advisors, LLC Tg Therapeutics, Inc. Call Options Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 07, 2022	SELL	$15.2 - $35.51 $7,600 - $17,755	-500 Reduced 33.33%	1,000 $19,000
Q3 2021 Nov 02, 2021	BUY	$21.78 - $40.45 $32,670 - $60,675	1,500 New	1,500 $50,000
Q2 2021 Jul 22, 2021	SELL	$32.5 - $48.96 $48,750 - $73,440	-1,500 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$25.27 - $54.9 $25,270 - $54,900	1,000 Added 200.0%	1,500 $78,000
Q3 2020 Oct 28, 2020	BUY	$18.49 - $27.24 $9,245 - $13,620	500 New	500 $13,000

338

88.3M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.